Sign in

CIK 0001158780 · Non-accelerated filer<br>Smaller reporting company

Ticker
PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
operating
EIN
980351734
Phone
972-74-710-7171
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
Former names
PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
  1. 4 Grant or award Director acquired 11,173 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 67,857 shares (grant or award)
  3. 4 Grant or award Director acquired 14,350 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 181,900 shares (grant or award)
  5. 4 Grant or award Director acquired 10,250 shares (grant or award)
  6. 4 Grant or award Director acquired 11,685 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Chief Executive Officer acquired 25,240 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 8,413 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 355,000 shares (grant or award)
  12. 4 Grant or award Director acquired 44,100 shares (grant or award)
  13. 4 Grant or award Director acquired 39,900 shares (grant or award)
  14. 4 Grant or award Director acquired 38,150 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 700,000 shares (grant or award)
  16. 4 Grant or award Director acquired 37,100 shares (grant or award)
  17. 4 Grant or award Director acquired 36,750 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award Chief Executive Officer acquired 334,821 shares (grant or award)

Page 2 of 18 · 352 filings